Sponsored Content | Case Study | Breast Imaging | April 09, 2020

Use of Mole Markers in DBT Improves Clinical Workflow and Patient Safety

Figure 1. R MLO view from four different years. The skin mole is marked with a circular skin marker (TomoSPOT REF# 782, Beekley Medical) on the far-left image. These images demonstrate the potential for significant variability in location of the skin lesion due to movability of the skin during positioning.

Figure 1. R MLO view from four different years. The skin mole is marked with a circular skin marker (TomoSPOT REF# 782, Beekley Medical) on the far-left image. These images demonstrate the potential for significant variability in location of the skin lesion due to movability of the skin during positioning. 

Figure 2. Mole marker (TomoSPOT REF# 782, Beekley Medical) on CC view.

Figure 2. Mole marker (TomoSPOT REF# 782, Beekley Medical) on CC view.

Figure 3. Corresponding mole marker (TomoSPOT REF# 782, Beekley Medical) on MLO view. Without mole marker, patient would have been called back for the CC finding.

Figure 3. Corresponding mole marker (TomoSPOT REF# 782, Beekley Medical) on MLO view. Without mole marker, patient would have been called back for the CC finding.

Christina Jacobs, M.D., Director of Breast Imaging (Bronson Health System) is always looking for ways to work more efficiently and improve the patient experience. She found that using skin markers not only facilitates the radiologist’s interpretation and improves workflow, it also helps reduce avoidable patient callbacks
and increases standardization across exams. 

At her institution, she uses markers with specific shapes to designate different areas of clinical concern such as palpable lumps, areas of pain or concern, scars, and moles or other skin lesions. This is in accordance with recent guidelines issued by the American College of Radiology (ACR).1 

Mammograms at Bronson Health are performed under both 2-D full field digital mammography (FFDM) and 3-D mammography or digital breast tomosynthesis (DBT). Jacobs prefers skin markers designed specifically for DBT as they generate less artifact. 

Moles Pose an Interpretation Challenge in DBT

While variation in equipment, technique, patient positioning and anatomy are commonplace in all mammography, DBT poses a unique set of challenges in identifying skin lesions compared to traditional 2-D digital mammography. 

According to Jacobs, using mole markers in DBT is helpful to address these challenges. 

• Some manufacturer’s equipment may add five extra reconstructed slices to the compression paddle side to eliminate the possibility of displaying the breast incompletely, thus causing a skin lesion to not appear on the initial slices. This means that in small breasts, lesions will appear to localize closer to the detector side of the scroll bar.1

• In addition, if the paddle flexes, an anterior skin lesion will be on a deeper slice because the breast is thickest at the chest wall.2 A skin lesion may not appear on the initial slices when the lesion is on a curved surface of the breast that is not in contact with the detector or compression plate. 

Rolling of the breast on the orthogonal view can change apparent skin lesion location and mislead the radiologist.3 In larger breasts, the craniocaudal (CC) view is more susceptible to this rolling of superficial tissue.4 

“This variation can result in things not being where you expect them to be on one view versus another,” Jacobs stated. “This can be especially true for superficial skin lesions in women whose breast tissue is pliable and stretches more. The way the tissue is spread out by the technologist also makes a difference. Moles that are closer to the chest wall where the tissue is less mobile tend to be more consistent and have less variation in their image location from view to view.”

Moles which are further out on the breast can be represented in significantly different locations as shown in Figure 1

If a skin lesion is in the lateral portion of the breast, the true lesion location will be inferior to what is shown on the mediolateral oblique (MLO) view. If the skin lesion is in the medial breast, the lesion will be superior to what is shown on the MLO view.2 

Mole Markers Reduce Avoidable Callbacks

To further emphasize how mole markers clarify findings and improve interpretation, Figure 2 shows a L CC view with a circular marker denoting a skin mole. Figure 3 shows the corresponding MLO view. The retroareolar asymmetry on the CC view would not be as obvious as corresponding to the skin lesion on the MLO view without the mole marker.  

“If the mole marker had not been used,” Jacobs explained, “this patient would have been called back for additional views. Having the skin marker lets you correlate with 100 percent certainty that it is the same finding on the two views.”

Improved Communication and Workflow

Having a protocol for the use of skin markers decreases the chance of misinterpretation and improves communication between the technologists and the radiologists. 

Jacobs recalled a case where a potential mass was identified on the CC view of a patient who was imaged without any markers. When the patient returned for additional imaging, the technologist noticed a mole in the area of concern and marked it with a circular mole marker, confirming that the suspected lesion was a skin mole and not a mass. 

“When our technologists use markers with specific shapes to indicate specific areas of concern it makes our workflow more efficient,” Jacobs stated. “When I’m reading an exam with skin markers, I know what each shape means. This facilitates efficient interpretation and reduces the need to review technologist’s notes on prior exams. It saves time, decreases callbacks, and makes it safer for the patient.” 

Breast Maps Alone Are Not Sufficient

Jacobs believes skin markers to be a more accurate documentation of the patient’s intake history than charting alone. 

“Our technologists are required to note the area of interest or concern on the breast map in our electronic reporting system. However, the drawing is just a mock-up and is not exactly what you see on the CC and MLO views. Patients have variability in their breast size and pliability of the breast tissue that can affect location on the image. It doesn’t always match the drawing, and the breast map doesn’t always correspond with where an area might end up on the actual image. It leaves room for potential misinterpretation. 

“Using skin markers has been very beneficial for our practice,” Jacobs continued. “They improve efficiency, workflow of our radiologists and improves communication between the technologists and radiologists. 

“For the patient, reducing callbacks means we can minimize inconvenience, anxiety, and additional radiation exposure. It makes the overall experience that much better for our patients,” she concluded. 

For more information: www.beekley.com

References:

1 The American College of Radiology, ACR BI-RADS® Atlas – Mammography, Digital Breast Tomosynthesis (DBT) Guidance, (A supplement to ACR BI-RADS® Mammography 2013), retrieved from https://www.acr.org/-/media/ACR/Files/RADS/BI-RADS/BI-RADS-Digital-Breast-Tomosynthesis-Supplement.pdf.

2 Ibid.

3 Lesion localization using the scroll bar on tomosynthesis: Why doesn’t it always work?, Friedewald, Sarah M. et al., Clinical Imaging, Volume 47, 57 - 64.

4 Ibid.    

Related Content

AI has the potential to help radiologists improve the efficiency and effectiveness of breast cancer imaging

Getty Images

Feature | Breast Imaging | May 28, 2020 | By January Lopez, M.D.
Headlines around the world the past several months declared that...
a Schematic of the system. The entire solid tumour is illuminated from four sides by a four-arm fibre bundle. A cylindrically focused linear array is designed to detect optoacoustic signals from the tumour. In vivo imaging is performed in conical scanning geometry by controlling the rotation and translation stages. The sensing part of the transducer array and the tumour are submerged in water to provide acoustic coupling. b Maximum intensity projections of the optoacoustic reconstruction of a phantom of pol

a Schematic of the system. The entire solid tumour is illuminated from four sides by a four-arm fibre bundle. A cylindrically focused linear array is designed to detect optoacoustic signals from the tumour. In vivo imaging is performed in conical scanning geometry by controlling the rotation and translation stages. The sensing part of the transducer array and the tumour are submerged in water to provide acoustic coupling. b Maximum intensity projections of the optoacoustic reconstruction of a phantom of polyethylene microspheres (diameter, 20 μm) dispersed in agar. The inset shows a zoomed-in view of the region boxed with a yellow dashed line. In addition, the yellow boxes are signal profiles along the xy and z axes across the microsphere centre, as well as the corresponding full width at half-maximum values. c Normalized absorption spectra of Hb, HbO2 and gold nanoparticles (AuNPs). The spectrum for the AuNPs was obtained using a USB4000 spectrometer (Ocean Optics, Dunedin, FL, USA), while the spectra for Hb and HbO2 were taken from http://omlc.org/spectra/haemoglobin/index.html. The vertical dashed lines indicate the five wavelengths used to stimulate the three absorbers: 710, 750, 780, 810 and 850 nm. Optoacoustic signals were filtered into a low-frequency band (red) and high-frequency band (green), which were used to reconstruct separate images.

News | Breast Imaging | May 26, 2020
May 26, 2020 — Breast cancer is the most common cancer in women.
Phone call and linkage-to-care-based intervention increases mammography uptake among primary care patients at an urban safety-net hospital

Getty Images

News | Mammography | May 22, 2020
May 22, 2020 — Telephone outreach coupled with scheduling assistance significantly increased...
The Breast Imaging and Reporting System (BI-RADS) was established by the American College of Radiology to help classify findings on mammography. Findings are classified based on the risk of breast cancer, with a BI-RADS 2 lesion being benign, or not cancerous, and BI-RADS 6 representing a lesion that is biopsy-proven to be malignant.

Getty Images

News | Breast Imaging | May 19, 2020
May 19, 2020 — Women with mammographically detected breast lesions that are probably benign should have follow-up sur
Podcast: Impact of COVID-19 on Breast Cancer Treatment with Dr. Andrea Madrigrano

Kubtec hosts a Podcast: Impact of COVID-19 on Breast Cancer Treatment with Andrea Madrigrano, M.D., as part of its public service campaign.

News | Coronavirus (COVID-19) | May 06, 2020
May 6, 2020 — The COVID-19 pandemic is an unprec
Two people together in an MRI Scanner along with the accompanying image of their brains

Two people together in an MRI Scanner along with the accompanying image of their brains. Image courtesy of Ville Renvall/ Aalto University

News | Magnetic Resonance Imaging (MRI) | April 30, 2020
April 30, 2020 — Researchers at Aalto University and...
The American Society of Breast Surgeons (ASBrS), the National Accreditation Program for Breast Centers (NAPBC), the National Comprehensive Cancer Network (NCCN), the Commission on Cancer (CoC) of the American College of Surgeons, and the American College of Radiology (ACR) have released new joint recommendations for prioritization, treatment and triage of breast cancer patients during the coronavirus (COVID-19) pandemic

Getty Images

News | Breast Imaging | April 13, 2020
April 13, 2020 — The American Society of Breast Surgeons (...